These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6210668)

  • 1. A randomized double blinded comparison of mezlocillin and ticarcillin for the treatment of respiratory infections.
    McCloskey RV; Killebrew D; Tutlane V; Bentley J
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():209-13. PubMed ID: 6210668
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: a prospective randomized trail.
    Ramírez-Ronda CH; Gutiérrez J; Bermúdez RH
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():125-9. PubMed ID: 6210660
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of mezlocillin and ticarcillin in the treatment of urinary tract infections.
    Madsen PO; Nielsen OS
    Clin Ther; 1980; 3(4):311-5. PubMed ID: 6456068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of complicated urinary tract infection with mezlocillin and ticarcillin, a comparative study.
    Madsen PO; Nielsen OS
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():179-81. PubMed ID: 6210665
    [No Abstract]   [Full Text] [Related]  

  • 5. Mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.
    Leal del Rosal P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():227-8. PubMed ID: 6210670
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.
    González MA
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():229-30. PubMed ID: 6210671
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of azlocillin and ticarcillin in the treatment of urinary tract infection.
    Reed WP; Palmer DL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():189-93. PubMed ID: 6619028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F; Li J; Gao L; Chen Y
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of azlocillin and ticarcillin in the treatment of complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1983 May; 11 Suppl B():183-8. PubMed ID: 6352601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of BRL28500 (clavulanic acid-ticarcillin) and ticarcillin in the treatment of respiratory tract infections].
    Miki F; Ikuno Y; Inoue E; Murata A; Tanizawa S; Sakamoto K; Tahara A; Saito A; Tomizawa M; Hiraga Y
    Kansenshogaku Zasshi; 1987 Aug; 61(8):944-79. PubMed ID: 3125285
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytosis and hyperkalemia associated with the use of ticarcillin/clavulanic acid.
    Moody SB; Pawlicki KS
    Drug Intell Clin Pharm; 1987 Mar; 21(3):292-3. PubMed ID: 3569032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and tolerability of intramuscular mezlocillin in severe respiratory tract infections].
    Calvanese F; Lauriello G; Perillo G; Savastano C; Gagliardi R
    G Ital Chemioter; 1980; 27(2):97-102. PubMed ID: 6210592
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the effectiveness of mezlocillin and ampicillin on respiratory tract infection (author's transl].
    Kansenshogaku Zasshi; 1981 Apr; 55(4):278-324. PubMed ID: 6457072
    [No Abstract]   [Full Text] [Related]  

  • 14. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.
    Levison ME; Kobasa WD
    Antimicrob Agents Chemother; 1984 Jun; 25(6):683-6. PubMed ID: 6742813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of mezlocillin in the treatment of urinary and respiratory tract infections].
    Polubiec A; Starzyńska R; Kubica I
    Pol Tyg Lek; 1982 Jul; 37(21):617-8. PubMed ID: 6216466
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic evaluation of the ticarcillin-clavulanic acid combination in severe nephrourologic infections.
    Dalet F; Torrellas A; Del Rio G
    Chemioterapia; 1987 Jun; 6(2 Suppl):512-3. PubMed ID: 3509486
    [No Abstract]   [Full Text] [Related]  

  • 18. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M; Ito T
    Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.
    van der Meer JW; Matze-van der Lans A; Mattie H
    Neth J Med; 1989 Jun; 34(5-6):233-42. PubMed ID: 2671757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of severe respiratory and urinary tract infections in older patients].
    Jansen W
    Fortschr Med; 1980 Jan; 98(1):(31)-(4). PubMed ID: 6900004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.